Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State—a PREVIEW Study
Open Access
- 25 April 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (7), e2511-e2520
- https://doi.org/10.1210/clinem/dgaa193
Abstract
Context Endocannabinoids are suggested to play a role in energy balance regulation. Objective We aimed to investigate associations of endocannabinoid concentrations during the day with energy balance and adiposity and interactions with 2 diets differing in protein content in participants in the post-obese phase with pre-diabetes. Design and participants Participants (n=38) were individually fed in energy balance with a medium protein (MP: 15:55:30% of energy from Protein:Carbohydrate:Fat) or high protein diet (HP: 25:45:30% energy from P:C:F) for 48-hours in a respiration chamber. Main outcome measures Associations between energy balance, energy expenditure, RQ and endocannabinoid concentrations during the day were assessed. Results Plasma-concentrations of anandamide (AEA), oleoylethanolamide (OEA), palmitoyethanolamide (PEA), and pregnenolone (PREG) significantly decreased during the day. This decrease was inversely related to BMI (AEA) or body-fat (%) (PEA; OEA). The lowest RQ value, before lunch, was inversely associated with concentrations of AEA and PEA before lunch. AUC of concentrations of AEA, 2-AG, PEA, and OEA were positively related to body-fat% (p<0.05). The HP and MP groups showed no differences in concentrations of AEA, OEA, PEA, and PREG, but the AUC of 2-arachidonoylglycerol (2-AG) was significantly higher in the HP vs. the MP group. Conclusions In energy balance, only the endocannabinoid 2-AG changed in relation to protein level of the diet, while the endocannabinoid AEA, and endocannabinoid-related compounds OEA and PEA reflected the gradual energy intake matching energy expenditure over the day.Keywords
Funding Information
- EU 7th Framework Programme (312057)
- Dutch Organization for Scientific Research (015.010.034)
This publication has 41 references indexed in Scilit:
- Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesityInternational Journal of Obesity, 2011
- Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy ExpenditureJournal of Clinical Endocrinology & Metabolism, 2011
- Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjectsActa Endocrinologica, 2009
- Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factorsDiabetologia, 2008
- Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese menInternational Journal of Obesity, 2007
- LC‐MS‐MS Analysis of Neutral EicosanoidsMethods in Enzymology, 2007
- Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal ObesityDiabetes, 2006
- Evolutionary origins of the endocannabinoid systemGene, 2006
- SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological CharacterizationThe Journal of pharmacology and experimental therapeutics, 2004
- Energy intake, physical activity and body weight: a simulation modelBritish Journal of Nutrition, 1995